Published in Gastroenterology on December 06, 2013
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer (2016) 1.46
Adulthood Weight Change and Risk of Colorectal Cancer in the Nurses' Health Study and Health Professionals Follow-up Study. Cancer Prev Res (Phila) (2015) 1.10
Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn (2015) 0.94
Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94
Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells. Front Physiol (2014) 0.93
Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer (2014) 0.92
The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev (2015) 0.90
Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) (2014) 0.86
Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol (2014) 0.84
Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. Dig Dis Sci (2014) 0.83
Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. Am J Epidemiol (2015) 0.83
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer (2016) 0.81
The risk of colonic adenomas and colonic cancer in obesity. Best Pract Res Clin Gastroenterol (2014) 0.80
Gastroesophageal reflux disease and non-esophageal cancer. World J Gastroenterol (2015) 0.78
Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Does obesity promote the development of colorectal cancer? Expert Rev Anticancer Ther (2016) 0.77
Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon. Am J Physiol Gastrointest Liver Physiol (2015) 0.77
Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy. J Cancer Res Clin Oncol (2014) 0.77
Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis. Oncotarget (2015) 0.77
Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N Mice. PLoS One (2015) 0.77
Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance. Biochim Biophys Acta (2015) 0.76
An Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic Cancer. Medicine (Baltimore) (2015) 0.76
Endoscopic assessment and management of early esophageal adenocarcinoma. World J Gastrointest Oncol (2014) 0.76
Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc. Carcinogenesis (2016) 0.75
Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals. Clin Transl Gastroenterol (2017) 0.75
Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol (2016) 0.75
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer. Br J Cancer (2016) 0.75
Diet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer Incidence. J Nutr Metab (2017) 0.75
Influence of obesity and bariatric surgery on gastric cancer. Cancer Biol Med (2016) 0.75
Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms. Medicine (Baltimore) (2015) 0.75
Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice. J Gastroenterol (2016) 0.75
Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol (2017) 0.75
Genetically predicted high body mass index was associated with increased gastric cancer risk. Eur J Hum Genet (2017) 0.75
Obesity Increases Prevalence of Colonic Adenomas at Screening Colonoscopy: A Canadian Community-Based Study. Can J Gastroenterol Hepatol (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Inflammation and metabolic disorders. Nature (2006) 33.33
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Immunoassay of endogenous plasma insulin in man. J Clin Invest (1960) 25.67
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 14.15
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
Years of life lost due to obesity. JAMA (2003) 12.18
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell (2009) 11.52
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81
Wnt signalling and its impact on development and cancer. Nat Rev Cancer (2008) 8.37
The epidemiology of obesity. Gastroenterology (2007) 8.35
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol (1927) 7.64
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 6.73
Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol (2011) 6.17
Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes (2007) 6.11
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Identification and characterization of metabolically benign obesity in humans. Arch Intern Med (2008) 5.74
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology (2004) 4.67
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol (2003) 3.89
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr (2007) 3.66
Insulin-sensitive obesity. Am J Physiol Endocrinol Metab (2010) 3.46
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology (2002) 3.39
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes (2003) 3.29
Barrett's esophagus. Gastroenterology (2002) 3.27
Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev (2009) 3.25
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr (2007) 3.20
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol (2009) 3.14
Energy balance and colon cancer--beyond physical activity. Cancer Res (1997) 3.11
Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord (2002) 3.09
Obesity and cancer. Oncologist (2010) 3.01
Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem (2004) 3.01
Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet (2009) 2.97
Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 2.90
Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89
Leptin and cancer. J Cell Physiol (2006) 2.88
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab (2006) 2.73
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem (2009) 2.69
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest (1996) 2.68
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev (2006) 2.66
Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery (2009) 2.64
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors. Clin Cancer Res (2007) 2.61
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59
Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med (2011) 2.59
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 2.59
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology (2009) 2.55
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr (2007) 2.40
Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 2.39
Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA (2011) 2.28
Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr (2009) 2.22
A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology (2012) 2.21
Central adiposity and risk of Barrett's esophagus. Gastroenterology (2007) 2.20
Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab (1998) 2.17
Increased risk of colorectal cancer after obesity surgery. Ann Surg (2013) 2.17
Minireview: IGF, Insulin, and Cancer. Endocrinology (2011) 2.16
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut (2008) 2.05
Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol (2007) 1.96
Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem (2005) 1.96
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut (2004) 1.92
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res (1995) 1.89
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem (2008) 1.89
Obesity and colon cancer: does leptin provide a link? Int J Cancer (2004) 1.89
Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol (2009) 1.84
Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res (2004) 1.84
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab (2003) 1.84
IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle (2005) 1.79
Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab (2002) 1.76
The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75
Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J (2000) 1.75
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol (2003) 1.72
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol (2011) 1.72
Prevalence of Dyspepsia in Individuals with Gastro-Esophageal Reflux-Type Symptoms in the Community: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol (2017) 0.75